
Press Releases
Press Release
NanoString Technologies Releases Fourth Quarter and Full Year 2018 Operating Results and Provides 2019 Outlook
SEATTLE, March 07, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the…
Press Release
NanoString to Present at the 39th Annual Cowen Healthcare Conference
SEATTLE, March 04, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management…
Press Release
NanoString Showcases GeoMx and Hyb & Seq Platforms at 2019 Advances in Genome Biology and Technology (AGBT) Conference
Nine Studies of GeoMx DSP for High-Plex Spatial RNA Profiling and Three Studies of Hyb & Seq for Clinical ApplicationsSEATTLE, Feb. 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG),…
Press Release
NanoString to Host Inaugural Spatial Genomics Summit on Wednesday, February 27th at the 2019 Advances in Genome Biology and Technology (AGBT) Conference
Industry Experts to Provide Comprehensive Review of Emerging Spatial TechniquesSEATTLE, Feb. 25, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and…
Press Release
NanoString to Release Fourth Quarter and Fiscal Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019
SEATTLE, Feb. 21, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will…
Press Release
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE, Jan. 06, 2019…
Press Release
NanoString to Present at the 37th Annual J.P. Morgan Healthcare Conference
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management…
Press Release
United Kingdom’s National Institute for Health and Care Excellence (NICE) Recommends NanoString’s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualified Early-Stage Invasive Breast Cancer Patients
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that health officials from…
Press Release
NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology
40+ Abstracts Highlight the Value of the nCounter Platform in Hematology & Immuno-oncology, Including Thirteen that Demonstrate the Potential Utility of the LymphMark Lymphoma Subtyping TestSEATTLE, Nov. 29, 2018 (GLOBE…
Press Release
NanoString to Present at the Evercore ISI HEALTHCONx Conference
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management…
Press Release
NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a…
Press Release
NanoString Technologies Releases Operating Results for Third Quarter of 2018
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the…